ARS Wealth Advisors Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.8M Buy
177,518
+1,150
+0.7% +$135K 1.79% 14
2026
Q1
$21.2M Buy
176,368
+998
+0.6% +$115K 1.79% 17
2025
Q4
$18.5M Buy
175,370
+3,898
+2% +$366K 1.66% 16
2025
Q3
$14.4M Buy
171,472
+8,233
+5% +$678K 1.42% 22
2025
Q2
$12.9M Buy
163,239
+3,151
+2% +$250K 1.49% 23
2025
Q1
$14.4M Buy
160,088
+4,848
+3% +$453K 2.03% 22
2024
Q4
$15.4M Sell
155,240
-4,482
-3% -$462K 2.12% 18
2024
Q3
$18.1M Buy
159,722
+1,510
+1% +$179K 2.23% 15
2024
Q2
$19.6M Buy
158,212
+2,361
+2% +$304K 2.54% 13
2024
Q1
$20.6M Buy
155,851
+11,790
+8% +$1.45M 2.78% 11
2023
Q4
$15.7M Buy
144,061
+45,138
+46% +$4.69M 2.33% 13
2023
Q3
$10.2M Sell
98,923
-2,020
-2% -$218K 1.67% 20
2023
Q2
$11.6M Sell
100,943
-3,644
-3% -$414K 1.85% 16
2023
Q1
$11.1M Buy
104,587
+1,973
+2% +$213K 2.05% 14
2022
Q4
$11.4M Sell
102,614
-8,804
-8% -$900K 1.88% 16
2022
Q3
$9.6M Buy
111,418
+2,988
+3% +$267K 1.47% 25
2022
Q2
$9.89M Buy
108,430
+1,214
+1% +$108K 1.36% 26
2022
Q1
$8.8M Buy
107,216
+77
+0.1% +$6.07K 1.53% 25
2021
Q4
$8.21M Buy
107,139
+6,252
+6% +$498K 1.38% 25
2021
Q3
$7.58M Buy
+100,887
New +$7.67M 1.38% 24

Other funds holding MRK

ARS Wealth Advisors Group's MRK Position: Q2 2026 in Review

ARS Wealth Advisors Group increased its Merck (MRK) stake by 0.65% in Q2 2026, buying an estimated $135K and bringing the position to 177,518 shares worth $22.8M. The position accounts for 1.79% of the portfolio, ranked #14.

ARS Wealth Advisors Group first reported a position in MRK in Q3 2021 and has held it in 20 quarters since. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • ARS Wealth Advisors Group held 177,518 shares of Merck worth $22.8M as of Q2 2026.
  • ARS Wealth Advisors Group bought 1,150 Merck shares in Q2 2026, an estimated $135K.
  • Merck made up 1.79% of ARS Wealth Advisors Group's portfolio in Q2 2026, its #14 holding.
  • ARS Wealth Advisors Group first reported a position in Merck in Q3 2021 and has held it in 20 quarters since.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on ARS Wealth Advisors Group's 13F filing for Q2 2026, filed 16 Jul 2026.